ACET Q3 2020 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+143.0% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$14M-451.0% margin

Net Income

-$15M-488.1% margin

EPS (Diluted)

$-12.80

QoQ Revenue Growth

-59.4%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$150M

Total Liabilities

$33M

Stockholders' Equity

$117M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	-$7M	+143.0%
Gross Profit	$3M	-$7M	+143.0%
Operating Income	-$14M	-$15M	+10.3%
Net Income	-$15M	-$15M	-0.0%